What question did this study set out to answer?

This research examines the availability of screening for blood-borne viruses and PrEP in treatment facilities for stimulant use disorders.

January 25, 2026

Availability of Screening for Blood-Borne Viruses, Sexually Transmitted Infections, and HIV Pre-Exposure Prophylaxis (PrEP) at U.S. Substance Use Treatment Facilities Treating Stimulant Use Disorder.

View Full Paper

Ask AI

Bookmark

Authors

Analysis shows limited screening and PrEP services in substance use treatment facilities, suggesting urgent need for service expansion.

This research examines the availability of screening for blood-borne viruses and PrEP in treatment facilities for stimulant use disorders.
Survey of U.S. substance use treatment facilities
Assessment of services provided related to HIV, HCV, STI testing and PrEP
Evaluation of biospecimen collection practices
Few facilities offered comprehensive testing for HIV, HCV, and STIs
Many facilities collected biospecimens but did not provide related testing or treatment
Highlighting the need for integrated prevention and management services

Bunting et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark